- Report
- January 2026
- 191 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 180 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 191 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 191 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 199 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 193 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 181 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 183 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 193 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 194 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 199 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 193 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 192 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 189 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 189 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 197 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 194 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 191 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 195 Pages
Global
From €3504EUR$3,939USD£3,037GBP
- Report
- January 2026
- 187 Pages
Global
From €3504EUR$3,939USD£3,037GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more